G-III Apparel Group, Ltd. Announces Second Quarter Fiscal

New Post Public Reply Private Reply Replies (0) Message Board
Serial Investor

G-III Apparel Group, Ltd. Announces Second Quarter Fiscal 2013 Results

-- Net Sales Increase 9.4% to $251.5 million --

-- Exceeds Guidance with Second Quarter Non-GAAP Net Income Per Share of $0.13 --

-- GAAP Net Income Per Share is $0.07 --

-- Full Year Guidance for Non-GAAP Net Income Per Share Increased by $0.12 to $2.74 to $2.84 --

NEW YORK--(BUSINESS WIRE)-- G-III Apparel Group, Ltd. (NasdaqGS: GIII) today announced operating results for the second quarter of fiscal 2013.

For the quarter ended July 31, 2012, G-III reported that net sales increased by 9.4% to $251.5 million from $230.0 million in the year-ago period.

The Company's net income for the second quarter was $1.4 million, or $0.07 per diluted share, compared to net income of $1.6 million, or $0.08 per diluted share, in the prior year's comparable period. On an adjusted basis, excluding expenses associated with the Company's acquisition of Vilebrequin, non-GAAP net income per diluted share for the second quarter was $0.13. A reconciliation of GAAP net income per share to non-GAAP net income per share is presented in a table accompanying the condensed financial statements included in this release.

Morris Goldfarb, G-III's Chairman and Chief Executive Officer, said, "This was an excellent second quarter. We have exceeded our short-term financial goals, built an order book that supports our annual plan, and completed the acquisition of a powerful, global brand in the men's luxury market. This combination of financial, operational and strategic progress, along with a strong balance sheet that supports further business development, gives us confidence that we are well positioned to drive superior value to our shareholders both now and well into the future."

Mr. Goldfarb concluded, "At present, we are focused on shipping for our peak Fall selling season, as well as integrating Vilebrequin's operations into our business. We are also off to a good start with our Spring '13 market showings to retailers. We feel very good about our ability to deliver solid profit improvements in both the third and fourth quarter this year over last year."

Outlook

The Company today revised its prior guidance for the full fiscal year ending January 31, 2013. The Company is now forecasting net sales of approximately $1.41 billion and net income between $55.2 million and $57.2 million, or a range of $2.68 and $2.78 per diluted share, compared to its previous guidance of net sales of approximately $1.35 billion and net income between $54.0 million and $56.0 million, or a range of $2.62 and $2.72 per diluted share. The forecasted net income and net income per share for the full fiscal year reflect the expenses of the Vilebrequin acquisition incurred through July 31, 2012, but do not reflect any additional expenses or integration costs related to this acquisition that may be incurred in the second half of the fiscal year. Non-GAAP net income per diluted share for the full fiscal year is now forecast to range between $2.74 and $2.84. The Company's previous guidance did not include any acquisition or integration expenses.

The Company is now projecting adjusted EBITDA for fiscal 2013 to increase approximately 17% to 21% to between $108.2 million and $111.5 million compared to its previous guidance of between approximately $102.5 million and $106.0 million.

The forecasted non-GAAP net income per share and forecasted adjusted EBITDA for the full fiscal year reflect adjustments that exclude the expenses of the Vilebrequin acquisition incurred through July 31, 2012.

Non-GAAP net income per share and adjusted EBITDA should be evaluated in light of the Company's financial results prepared in accordance with U.S. GAAP. Reconciliations of forecasted GAAP net income per share to forecasted non-GAAP net income per share and of GAAP net income to adjusted EBITDA are included in tables accompanying the condensed financial statements in this release.

For its third fiscal quarter ending October 31, 2012, the Company is forecasting net sales of approximately $570 million compared to $510 million in the comparable quarter last year. The Company is also forecasting net income for the third fiscal quarter between $46.4 million and $48.4 million, or between $2.25 and $2.35 per diluted share, compared to net income of $43.6 million, or $2.16 per diluted share, in last year's third quarter. The Company's forecast for the third fiscal quarter does not take into account any additional expenses or integration costs that may be incurred during the quarter with respect to the acquisition of Vilebrequin.

About G-III Apparel Group, Ltd.

G-III is a leading manufacturer and distributor of outerwear, dresses, sportswear, swimwear, beachwear and women's suits, as well as handbags and luggage, under licensed brands, our own brands and private label brands. G-III sells swimwear and beachwear under our own Vilebrequin brand. G-III also sells outerwear and dresses under our own Andrew Marc, Marc New York and Marc Moto brands and has licensed these brands to select third parties in certain product categories. G-III has fashion licenses under the Calvin Klein, Sean John, Kenneth Cole, Cole Haan, Guess?, Jones New York, Jessica Simpson, Vince Camuto, Nine West, Ellen Tracy, Tommy Hilfiger, Kensie, Mac & Jac, Levi's and Dockers brands and sports licenses with the National Football League, National Basketball Association, Major League Baseball, National Hockey League, Touch by Alyssa Milano and more than 100 U.S. colleges and universities. Our other owned brands include Jessica Howard, Eliza J, Black Rivet, G-III, G-III Sports by Carl Banks and Winlit. G-III also operates outlet stores under our Wilsons Leather and Andrew Marc names, is a party to a joint venture that operates outlet stores under the Vince Camuto name and operates retail stores under the Calvin Klein Performance name.

Statements concerning G-III's business outlook or future economic performance, anticipated revenues, expenses or other financial items; product introductions and plans and objectives related thereto; and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters are "forward-looking statements" as that term is defined under the Federal Securities laws. Forward-looking statements are subject to risks, uncertainties and factors which include, but are not limited to, reliance on licensed product, reliance on foreign manufacturers, risks of doing business abroad, the current economic and credit environment, the nature of the apparel industry, including changing customer demand and tastes, customer concentration, seasonality, risks of operating a retail business, customer acceptance of new products, the impact of competitive products and pricing, dependence on existing management, possible disruption from acquisitions and general economic conditions, as well as other risks detailed in G-III's filings with the Securities and Exchange Commission. G-III assumes no obligation to update the information in this release.

G-III APPAREL GROUP, LTD. AND SUBSIDIARIES

(NASDAQGSM:GIII)

CONSOLIDATED STATEMENTS OF OPERATIONS AND

SELECTED BALANCE SHEET DATA

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended

July 31,

Six Months Ended

July 31,

2012

2011

2012

2011

Net sales $ 251,479 $ 229,975 $ 480,928 $ 426,846
Cost of sales 176,636 164,404 337,395 301,820
Gross profit 74,843 65,571 143,533 125,026
Selling, general and administrative expenses

69,454

59,826

136,068

117,751

Depreciation and amortization 2,100 1,852 4,153 3,376
Operating profit 3,289 3,893 3,312 3,899
Equity loss in joint venture 146 376 433 475
Interest and financing charges, net 1,034 952 2,138 1,711
Income before taxes 2,109 2,565 741 1,713
Income tax expense 802 1,000 282 668
Net income 1,307 1,565 459 1,045
Add: Loss attributable to noncontrolling interest (55 ) - (55 ) -
Income attributable to G-III $ 1,362 $ 1,565 $ 514 $ 1,045
Net income per common share:
Basic $ 0.07 $ 0.08 $ 0.03 $ 0.05
Diluted $ 0.07 $ 0.08 $ 0.03 $ 0.05
Weighted average shares outstanding:
Basic 19,995 19,848 19,928 19,784
Diluted 20,331 20,253 20,334 20,221
Selected Balance Sheet Data (in thousands): At July 31,

2012

2011

Cash $ 22,653 $ 8,566
Working Capital 297,144 240,431
Inventory 336,389 322,387
Total Assets 662,343 618,395
Short-term Revolving Debt 87,007 141,974
Total Stockholders' Equity 364,172 309,679

G-III APPAREL GROUP, LTD. AND SUBSIDIARIES

RECONCILIATION OF ACTUAL AND FORECASTED GAAP NET INCOME PER SHARE TO

ACTUAL AND FORECASTED NON-GAAP NET INCOME PER SHARE

(Unaudited)

Three Months Ended

July 31,

Six Months Ended

July 31,

2012

2011

2012

2011

GAAP diluted net income per common share

$ 0.07 $ 0.08 $ 0.03 $ 0.05

Excluded from Non-GAAP:

Expenses associated with Vilebrequin acquisition, net of taxes

0.06

-

0.06

-

Non-GAAP diluted net income per common share

$

0.13

$

0.08

$

0.09

$

0.05

Forecasted Twelve Months Actual Twelve Months
Ending January 31, 2013 Ended January 31, 2012

GAAP diluted net income per common share

$2.68 - $2.78 $ 2.46

Excluded from Non-GAAP:

Expenses associated with Vilebrequin acquisition, net of taxes

0.06

-

Non-GAAP diluted net income per common share

$2.74 - $2.84

$ 2.46

Non-GAAP diluted net income per share is a "non-GAAP financial measure" that excludes the expenses associated with the acquisition of Vilebrequin. The non-GAAP information in the tables above reflects an adjustment for expenses associated with the Vilebrequin acquisition that were incurred through July 31, 2012, but does not reflect expenses and integration costs that may be incurred in the second half of the fiscal year. Management believes that this non-GAAP financial measure provides meaningful supplemental information regarding our performance by excluding discrete expenses and integration costs associated with the acquisition of Vilebrequin that are not indicative of our core business operating results. Management uses this non-GAAP financial measure to assess our performance on a comparative basis and believes that it is also useful to investors to enable them to assess our performance on a comparative basis across historical periods and facilitate comparisons of our operating results to those of our competitors. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

G-III APPAREL GROUP, LTD. AND SUBSIDIARIES

RECONCILIATION OF FORECASTED AND ACTUAL NET INCOME TO FORECASTED

AND ACTUAL ADJUSTED EBITDA

(In thousands)

(Unaudited)

Forecasted Actual
Twelve Months Ending Twelve Months Ended

January 31, 2013

January 31, 2012

Net income $55,200 - $57,200 $ 49,620
Expenses associated with Vilebrequin acquisition 1,800 -
Depreciation and amortization 9,700 7,473
Interest and financing charges, net 7,700 5,713
Income tax expense 33,800 - 35,100 29,620
Adjusted EBITDA, as defined $108,200 - $111,500 $ 92,426

Adjusted EBITDA is a "non-GAAP financial measure" which represents earnings before depreciation and amortization, interest and financing charges, net, and income tax expense and excludes expenses related to the acquisition of Vilebrequin. The non-GAAP information in the table above reflects an adjustment for expenses associated with the Vilebrequin acquisition that were incurred through July 31, 2012, but does not reflect expenses and integration costs that may be incurred in the second half of the fiscal year. Adjusted EBITDA is being presented as a supplemental disclosure because management believes that it is a common measure of operating performance in the apparel industry. Adjusted EBITDA should not be construed as an alternative to net income as an indicator of the Company's operating performance, or as an alternative to cash flows from operating activities as a measure of the Company's liquidity, as determined in accordance with generally accepted accounting principles.

For G-III Apparel Group, Ltd.:
Investor Relations
James Palczynski, 203-682-8229
or
G-III Apparel Group, Ltd.
Neal S. Nackman, 212-403-0500
Chief Financial Officer

Source: G-III Apparel Group, Ltd.

G-III Apparel Group (GIII) Stock Research Links

GIII Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

NORBIT Secures Significant NOK 120M Defence Order

Updated Category News Views 288

NORBIT Secures Significant NOK 120 Million Defence Order NORBIT has recently made an exciting announcement regarding a significant contract within its segment PIR. The company has been awarded a manufacturing order valued at NOK 120 million from a European client specializing in defence and security. This order is poised for delivery in late 2025 and early 2026, marking a...

Continue Reading
Shareholder Concerns Over BCO, SEM, NATL Transactions

Updated Category News Views 12

Is There Smoke Without Fire in Recent Company Mergers? Well, here we go again. It seems every time deals like these pop up, questions start flying about fairness and insider scoops. The big fish here? The Brink's Company (NYSE:BCO), Select Medical Holdings Corporation (NYSE:SEM), and NCR Atleos Corporation (NYSE:NATL). Halper Sadeh LLC, the investor rights firm, is on a...

Continue Reading
TG Therapeutics Director’s Recent Stock Sale Raises Questions

Updated Category News Views 120

Significant Insider Transaction at TG Therapeutics Recently, an important transaction came to light involving Yann Echelard, Director at TG Therapeutics (NASDAQ:TGTX). The details were revealed through the latest SEC filing. On a given date, Echelard sold 5,000 shares, raising a total of $162,850. Such insider trading can often prompt discussions regarding the company’s...

Continue Reading
Innovative Leadership in Facilities Management Revolutionized

Updated Category News Views 214

MasonMade Ventures Launches to Revamp Facilities Management Serial Entrepreneurs Aim to Disrupt the FM Industry through Innovative Software Solutions and Expert Trades MasonMade Ventures, established by visionary entrepreneurs Joseph Scaretta and Moses Carrasco, is set to change the face of facilities management. This operational holding company focuses on investing in...

Continue Reading
Kyverna Therapeutics Engages Investors at Upcoming Events

Updated Category News Views 136

Kyverna Therapeutics' Upcoming Investor Conferences Kyverna Therapeutics, Inc. (NASDAQ: KYTX), a pioneering clinical-stage biopharmaceutical company committed to innovative cell therapies for autoimmune diseases, is slated to present at a series of significant investor conferences this September. Warner Biddle, the Chief Executive Officer of Kyverna, will be the...

Continue Reading